Cigarettes-Tobacco Products company ITC announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Q4: Gross Revenue up 9.2% YoY and EBITDA up 2.5% YoY (ex-Paper, up 4.2% YoY) Gross revenue rose by 9.2% to Rs 18,266 crore rupees. EBITDA increased by 2.5% to Rs 5,986 crore rupees. PBT grew by 2.1% to Rs 6,417 crore rupees. PAT went up by 0.8% to Rs 4,875 crore rupees. FY25 Financial Highlights: Gross revenue rose 10.2% to Rs 73,465 crore rupees. EBITDA increased 2.3% to Rs 24,025 crore rupees. PBT grew 3.5% to Rs 26,529 crore rupees. PAT was up 0.9% to Rs 20,092 crore rupees. Full Year: Gross Revenue up 10.2% YoY and EBITDA up 2.3% YoY (ex- Paper, up 4.4% YoY) Overall Profit After Tax for FY25 (including Profit from Discontinued Operations) stood at Rs. 35196 crores. Segment Highlights Resilient performance in FMCG–Others Segment amidst subdued demand conditions and sharp escalation in input costs Full Year: Segment Revenue up 4.8% YoY; up 6.2% YoY ex-Notebooks Q4: Segment Revenue up 3.7% YoY; up 5.4% YoY ex-Notebooks Cigarettes Net Segment Revenue up 7.1% YoY & Segment PBIT up 4.9% YoY for the Full Year Q4: Net Segment Revenue up 6.0% YoY; Segment PBIT up 4.0% YoY Robust growth in Agri Business Segment led by Leaf Tobacco, Value Added Agri Products and Rice exports Full Year: Segment Revenue and Segment PBIT up 25% and 18% YoY respectively Q4: Segment Revenue and Segment PBIT up 18% and 26% YoY respectively Result PDF
Pharmaceuticals company Sun Pharmaceutical Industries announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Gross sales at Rs 128,156 million, growth of 8.5% India formulation sales at Rs 42,130 million, up 13.6% US formulation sales at USD 464 million, down 2.5% Global Specialty sales at USD 295 million, up 8.6%, accounting for 19.9% of Q4FY25 sales Emerging Markets formulation sales at USD 261 million, up 6.3% Rest of World formulation sales at USD 200 million, up 2.0% R&D; investments at Rs 8,166 million EBITDA at Rs 37,161 million (including other operating revenues), up 22.4%, with resulting EBITDA margin of 28.7% Adjusted net profit (excluding the exceptional items) for Q4FY25 was Rs 28,891 million, up 4.8%. Reported net profit for Q4FY25 was Rs 21,499 million compared to Rs 26,546 million during Q4FY24 FY25 Financial Highlights: Gross sales at Rs 520,412 million, growth of 9.0% India formulation sales at Rs 169,230 million, up 13.7% US formulation sales at USD 1,921 million, up 3.6% Global Specialty sales at USD 1,216 million, up 17.1%, accounting for 19.7% of FY25 sales Emerging Markets formulation sales at USD 1,114 million, up 7.0% Rest of World formulation sales at USD 847 million, up 4.5% EBITDA at Rs 152,717 million (including other operating revenues), up 17.3%, with resulting EBITDA margin of 29.0% Adjusted net profit (excluding the exceptional items) for FY25 was Rs 119,844 million, up 19.0%. Reported net profit for FY25 was Rs 109,290 million compared to Rs 95,764 million during FY24. Dilip Shanghvi, Chairman and Managing Director of the Company said, "Our businesses delivered a robust performance for the year, driven by improving market share in India and growth in Global Specialty. The nearterm pipeline in Global Specialty is promising, with products such as Leqselvi and Unloxcyt—the latter through our recently announced Checkpoint acquisition—offering significant improvements in patient care. We look forward to Specialty becoming an increasingly important part of our business." Result PDF
IndusInd Bank announced Q4FY25 & FY25 results Q4FY25 & FY25 Financial Highlights: The Bank has reported a full year Net Profit After Tax of Rs 2,575 crore The Capital Adequacy of the Bank remains robust at 16.24% after absorbing all the impact Net worth at Rs 62,532 crore in Q4FY25 as compared to Rs 61,445 crore in Q4FY24 The Bank has healthy liquidity position with LCR of 118% average for Q4FY25 and continues to be comfortable with an LCR of 139% average for the first half of the ongoing Q1FY26. Net Interest Income for the year FY25 at Rs 19,031 crore as compared to year FY24 at Rs 20,616 crore. Fee and other income for the year FY25 at Rs 7,690 crore as compared to year FY24 at Rs 9,396 crore. Total Income (Interest Income and Fee Income) for year FY25 at Rs 56,358 crore as compared to Rs 55,144 crore for the corresponding year FY24. Operating expenses for the year FY25 were Rs 16,060 crore as against Rs 14,148 crore for the corresponding year FY24 Total expenditure (Interest expended and Operating expenses) for FY25 at Rs 45,696 crore as compared to Rs 39,280 crore for the corresponding FY24 Pre Provision Operating Profit (PPOP) at Rs 10,661 crore for year FY25 as against Rs 15,864 crore for corresponding year FY24 Commenting on the performance, Sunil Mehta, the Chairman of the Board of Directors, IndusInd Bank said: “The Board and the Management acknowledge that the lapses happened have been unfortunate for an institution like our Bank. However, the Board along with the management have shown a strong resolve to address all the identified issues in timely and comprehensive manner. The Bank has a robust Networth and balance sheet even after absorbing impact from all the past anomalies. The learnings from these incidents will be imbibed to reinforce the governance and compliance culture of the organisation. The Bank at its core has profitable business model and it will pivot towards sustainable growth as we put this episode behind us. The Bank would like to express its gratitude to the regulators and particularly the RBI for its support and guidance in helping navigating these challenging times.” Commenting on the performance, Soumitra Sen and Anil Rao, the members of the Committee of Executives, IndusInd Bank said: “The Bank’s core competencies remain strong which allows it to take these challenges in its stride. We are confident that the Bank will emerge stronger as the foundation will become robust incorporating the learnings from recent events. The management is committed to ensure interests of all the stakeholders are protected and deliver on the near and long term growth agenda with unrelenting focus on governance. We are thankful to the Board for their continued guidance and direction, all the employees who have ensured smooth customer service in current times, the regulators as well as shareholders in helping the franchise and we look forward to their continued support.” Result PDF